Skip to main content
Clinical Trials/EUCTR2018-001291-38-NL
EUCTR2018-001291-38-NL
Active, not recruiting
Phase 1

In vivo efficacy of Salbutamol Sandoz versus salbutamol Ventolin GSK in children with asthma - Salsa

Radboud University Medical Center0 sites80 target enrollmentJune 4, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Asthma in children
Sponsor
Radboud University Medical Center
Enrollment
80
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Informed consent of the parents of children up to 12 yrs of age, and informed consent from parents/caretakers of children and of the children aged 12\-14 years. van ouders bij kinderen tot 12 jaar, en informed consent van ouders en assent van kinderen bij de leeftijd van 12\-14 jaar
  • \- Children known with doctor’s diagnosed asthma, and a history, or physical examanation, or documented positive response on bronchodilators following lung function testing, indicating reversibility of airways obstruction
  • \- C\-ACT (children astma controle test questionnaire 4\-11 yrs) or ACT(12\-16 yrs) \<20 and/or FEV1 decline of at least 15% compared to personal's best and/or FEV1 \< 80 % of predicted value and/or such symptoms that the parents or the physician would administer a bronchodilator
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 80
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • \- Severe acute asthma for which high and frequent dosages of Salbutamol are needed
  • \- Inability to conduct a lung function test well
  • \- Inability to read or understand the Dutch Language
  • \- Concomitant other chronic physical or mental condition that precludes conducting a reliable lung function test.

Outcomes

Primary Outcomes

Not specified

Similar Trials